| 【Company Research】Redsun (1996 HK) – Explore out of Jiangsu |
| 【Company Research】Xinhua Education (2779 HK) – Waiting for next acquisition |
| 【Company Research】FriendTimes Inc. (6820 HK) – Moving to strong FY20E with eye-catching ToE |
| 【Company Research】China Construction Bank (939 HK) – Strong defensiveness against macro downturn |
| 【Company Research】PICC P&C (2328 HK) – Look to rebound after COVID-19 |
| 【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – Inline results; Moderate impact from COVID-19 |
| 【Company Research】WuXi Biologics (2269 HK) – Growth on track |
| 【Company Research】Bank of China (3988 HK) – Rising uncertainties from overseas exposure |
| 【Company Research】ICBC (1398 HK) – Steady outlook with manageable credit risk |
| 【Company Research】COLI (688 HK) – Double digit growth next three years |